EquityBulls

Latest News

Keywords Selected: Approval

IPO News

Stock Report

J B Chemicals and Pharmaceuticals Ltd receives ANDA approval for Amitriptyline Hydrochloride Tablets from USFDA
Hindoostan Mills Ltd receives permission for closure of Textile Unit
Gland Pharma Ltd receives EIR from US FDA for JNPC Facility, Visakhapatnam
Kabra Drugs Limited gets FDA nod for Chennai facility, to acquire companies
Purple Finance Limited allots 96,04,273 shares on rights basis, gets IRDAI registration as Corporate Agent
Equity Shares of Indosolar Ltd to list in NSE and BSE from June 19, 2025
NTPC consortium issued LoI as Successful Resolution Applicant for acquiring Sinnar Thermal Power Limited
RBI approves reappointment of Mr. Pralay Mondal as MD and CEO of CSB Bank Ltd
Scheme of merger between Inox Wind Energy and Inox Wind approved
Lupin receives tentative approval from U.S. FDA for Oxcarbazepine ER Tablets
MCX announces the launch of Electricity Derivatives - a landmark in India's energy-market evolution
Gland Pharma Receives Approval for Angiotensin II Acetate Injection
Alankit Ltd gets approval for increase of recruitment license capacity
Biocon Limited gets approval for diabetes drug Liraglutide in India
Zydus receives tentative approval from USFDA for Rifaximin Tablets, 550 mg
IIFL Finance receives approval to open branches in Jammu & Kashmir
Zydus receives final approval from USFDA for Isotretinoin Capsules USP, 10 mg 20 mg, 25 mg, 30 mg, 35 mg and 40 mg
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Amlodipine and Atorvastatin Tablets USP
Indoco Remedies receives final approval from the USFDA for Allopurinol Tablets USP 200 mg
Capital India Home Loans Ltd receives prior approval from RBI for sale and change in control of Capital India Home Loans Limited
Sun Pharma Announces FDA Approval of Next Generation BLU-U® Blue Light Photodynamic Therapy Illuminator for Actinic Keratosis
KRN's wholly owned subsidiary receives approval under PLI Scheme & granted incentives of ₹141.72 Cr
Lupin receives approval from U.S. FDA for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg
Alembic Pharmaceuticals receives USFDA Final Approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg

Industry News